The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACS) has granted Three-Year Accreditation to the cancer program at CHI St. Alexius Health Bismarck. To earn voluntary CoC accreditation, a cancer program must meet 34 CoC quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of comprehensive patient-centered care.
Because it is a CoC-accredited cancer center, CHI St. Alexius Health takes a multidisciplinary approach to treating cancer as a complex group of diseases that requires consultation among surgeons, medical and radiation oncologists, diagnostic radiologists, pathologists, and other cancer specialists. This multidisciplinary partnership results in improved patient care.
“CHI St. Alexius Health is pleased to be recognized again by the CoC and we are committed to quality cancer care. The CoC accreditation gives us the opportunity to highlight the exceptional care our physicians, nurses, and entire clinical team provide to our cancer patients. Our team approach successfully provides patients the highest quality care to ensure the safety with the best outcomes,” states Kurt Schley, President, CHI St. Alexius Health.
The CoC Accreditation Program provides the framework for CHI St. Alexius Health to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care including prevention, early diagnosis, cancer staging, optimal treatment, rehabilitation, life-long follow-up for recurrent disease, and end-of-life care. When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments, genetic counseling, and patient centered services including psycho-social support, a patient navigation process, and a survivorship care plan that documents the care each patient receives and seeks to improve cancer survivors’ quality of life.
Like all CoC-accredited facilities, CHI St. Alexius Health maintains a cancer registry and contributes data to the National Cancer Data Base (NCDB), a joint program of the CoC and American Cancer Society. This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care. CoC-accredited cancer centers, in turn, have access to information derived from this type of data analysis, which is used to create national, regional, and state benchmark reports. These reports help CoC facilities with their quality improvement efforts.